Delisting Determination, The Nasdaq Stock Market, LLC, April 25, 2024,
Eiger BioPharmaceuticals, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Eiger BioPharmaceuticals, Inc.,
effective at the opening of the trading session on May 6, 2024.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on April 2,
2024. The Company did not appeal the Staff determination to the
Hearings Panel. The Company securities were suspended on April 11,
2024. The Staff determination to delist the Company securities
became final on April 11, 2024.